pharma · Migraine · Narcolepsy
H. Lundbeck A/S
H. Lundbeck A/S is a pharma organization headquartered in Valby, CN. Primary therapeutic focus areas include Migraine, Narcolepsy, Schizophrenia, Multiple System Atrophy, Chronic Migrane, Migrane, Medication Overuse Head
Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN HQ
112 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN
- Employees
- 112
- Programs
- 17
- Drugs
- 14
- Patents
- 0
Lu AF28996 in Patients With Parkinson's Disease
Phase 1 · other · Parkinson's Disease
Lu AF28996 in Patients With Parkinson's Disease for Parkinson's Disease is a Phase 1 program (other) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Internal code 18252A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- H. Lundbeck A/S
- Phase
- Phase 1
- Modality
- other
- Indication
- Parkinson's Disease
- Status
- active
- Trials
- 1